ACURX PHARMACEUTICALS LLC reports a Return on Equity (ROE) of -106.92%.

What is ACXP's dividend yield?

ACURX PHARMACEUTICALS LLC offers a dividend yield of 0.00%.

What is ACXP's Quality Score?

Our AI rates ACXP's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy ACXP?

Our AI Timing Score for ACXP is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does ACXP belong to?

ACURX PHARMACEUTICALS LLC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange

ACXP (NASDAQ) Stock Analysis | ACURX PHARMACEUTICALS LLC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

ACXP AI Analysis Summary

Our AI summary for ACXP: ACURX PHARMACEUTICALS LLC (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -106.92%, a dividend yield of 0.00%. Its financial Quality Score stands at 54/100 — mid-range fundamentals relative to the market. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

ACXP

ACURX PHARMACEUTICALS LLC

US:NASDAQ STOCK Healthcare >> Biotechnology News 83

USD 1.44

0.02 (1.41%) Day Change

Watchlist Portfolio Compare Chart

0.36

D/E

-106.9%

ROE

-78.6%

ROA

0.00%

Div Yield

ACURX PHARMACEUTICALS LLC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 1.44 Price 0.02 (1.41%) Day Change	NEWS SCORE: 83

ACXP, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Quality Factors

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	83
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.44
PBV / Sector	0.87 / 5.20 GREAT
Earning Per Share	-1.77

PE / Sector	N/A / 19.97
PEG or PE/Growth / Sector	N/A / 1.22
Average 1M Daily Value	0.14 M GREAT
Average 1W Daily Value	0.09 M GREAT

Timing Factors

28%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

47%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 98.71
NPM Average (%) / Sector	N/A / -1,721.76
NPM Change Average (%) / Sector	N/A / 5,211.62
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-78.60 / 27.02
ROA Average (%) / Sector	-173.16 / -368.17
ROA Change Average (%) / Sector	11.04 / 5,404.12 GOOD
ROE (%) / Sector	-106.92 / 3.47
ROE Average (%) / Sector	-605.71 / 6.51
ROE Change Average (%) / Sector	150.06 / 2,128.13 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -1.75

Registration Details

Analyze Date	2026-08-01 07:59:25
Symbol	ACXP
Name	ACURX PHARMACEUTICALS LLC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	4.30 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	6.10 / 9,903.94

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305

Phone: 917 533 1469

Website: https://www.acurxpharma.com

Sector: Healthcare >> Biotechnology

Description: Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.